<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0015">
 <label>Table 3</label>
 <caption>
  <p>Impacts of CCR5Δ32 on Human papillomavirus (HPV) infection.</p>
 </caption>
 <alt-text id="at0095">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Population</th>
    <th align="left">Sample</th>
    <th align="left">Main findings</th>
    <th align="left">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Swedish</td>
    <td align="left">126 HPV-infected individuals; 173 non-infected individuals</td>
    <td align="left">CCR5Δ32 homozygous genotype was associated with increased risk of HPV infection</td>
    <td align="left">
     <xref rid="bib1685" ref-type="bibr">Zheng et al. (2006)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Brazilian</td>
    <td align="left">74 HPV-infected individuals; 43 non-infected individuals</td>
    <td align="left">No association between CCR5Δ32 and HPV infection; No association between CCR5Δ32 and HPV-related cancer</td>
    <td align="left">
     <xref rid="bib1445" ref-type="bibr">Suzuki et al. (2008)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Brazilian</td>
    <td align="left">139 HPV-infected individuals with cervical intraepithelial neoplasia or cervical cancer; 151 HPV-infected individuals without cervical lesions</td>
    <td align="left">No association between CCR5Δ32 and HPV-related lesions; No association between CCR5Δ32 and HPV genotypes</td>
    <td align="left">
     <xref rid="bib1300" ref-type="bibr">Santos et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Brazilian</td>
    <td align="left">164 HPV-infected individuals; 185 non-infected individuals</td>
    <td align="left">No statistically significant effect of CCR5Δ32 on susceptibility to HPV infection or HPV-related cervical lesions (low‐grade squamous intraepithelial lesion or high‐grade squamous intraepithelial lesion)</td>
    <td align="left">
     <xref rid="bib0975" ref-type="bibr">Mangieri et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Lithuanian</td>
    <td align="left">49 laryngeal squamous cell carcinoma patients (21 HPV-infected patients and 28 non-infected patients)</td>
    <td align="left">No statistically significant effect of CCR5Δ32 on susceptibility to HPV infection, clinical-pathological characteristics or surviving rates</td>
    <td align="left">
     <xref rid="bib1425" ref-type="bibr">Stumbrytė-Kaminskienė et al. (2020)</xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
